Clinical trial

Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney)…

NCT00141037 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed

Key facts

NCT number NCT00141037
Title Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation
Official title Randomized, Multi-Center Comparative Trial of Tacrolimus w/Steroids and Standard Daclizumab Induction vs a Novel Steroid-Free Tacrolimus Based Immunosuppression Protocol w/ Extended Daclizumab Induction in Pediatric Renal Transplantation
Lead sponsor National Institute of Allergy and Infectious Diseases (NIAID), NIH
Collaborators Astellas Pharma Inc Industry Hoffmann-La Roche
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Kidney Diseases, Kidney Transplantation, Kidney Transplant, Renal Transplantation, Renal Transplant
Intervention type Drug
Interventions Daclizumab, Mycophenolate mofetil (MMF), Prednisone, Tacrolimus, Ganciclovir, Valganciclovir, Trimethoprim and sulfamethoxazole
Enrollment 130
Start date Mar 1, 2004
Primary completion Sep 1, 2006
Completion Nov 1, 2010
First posted Sep 1, 2005
Last update posted Nov 29, 2016
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies